Organization attributes
Other attributes
Elcelyx Therapeutics is a biotechnology company developing products for weight management and obesity-related metabolic disorders that is headquartered in San Diego, California and was founded in 2010 by Alain D. Baron.
On March 17, 2010 Elcelyx Therapeutics completed their series A funding round with $1.2 million in funding from undisclosed investors.
On August 13, 2012 Elcelyx Therapeutics completed their series B funding round with $4 million in funding from Morgenthaler Ventures, Kleiner Perkins Caufield & Byers, and Technology Partners.
On February 24, 2014 Elcelyx Therapeutics completed their series C funding round with $20 million in funding from Technology Partners, Morgenthaler Ventures, Kleiner Perkins, and GMS Fund.
On February 23, 2015 Elcelyx Therapeutics completed their series D funding round with $5.8 million in funding from undisclosed investors.
On October 5, 2015 Elcelyx Therapeutics completed their series E funding round with $40 million in funding from Sailing Capital (lead investor), Clough Capital Partners, Morgenthaler Ventures, Kleiner Perkins Caufield & Byers, Technology Partners, and GSM Fund.
